Gelteq Limited (GELS)

NASDAQ: GELS · USD

$0.47

+0.01 (+1.7%)· Recorded snapshot

Market cap	5.2M
Revenue (ttm)	314.7K
Net income (ttm)	-4.7M
EPS (ttm)	-$0.47
Shares out	11.2M
Volume	11,747
Beta	-0.39

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 314.7K
Net income (ttm): -4.7M
EPS (ttm): -$0.47
Market cap: 5.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-42.9

P25 n/aP50 n/aP75 n/a

ROIC-19

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All GELS indicators

Market & fundamental data

Available fields

185

Groups with data

Currency

AUD

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001920092
Company name	Gelteq Limited
Country	Australia
Country code	US
Earnings date	2026-11-17
Earnings time	bmo
Employees	8
Employees change	5
Employees growth	166.67%
Enterprise value	$8.6M
Exchange	NASDAQ
Financial currency	AUD
Financial report date	2025-12-31
First seen	2026-05-09
Fiscal year end	June
Founded	2018
Industry	Drug Manufacturers - Specialty & Generic
IPO date	2024-10-29
Is primary listing	Yes
Is SPAC	No
ISIN number	AU0000218109
Last 10-K release date	2025-11-17
Last earnings date	2026-06-30
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$5.2M
Market cap category	Nano-Cap
Next earnings date	2026-11-17
Options	No
Price	$0.47
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	GELS
Website	https://www.gelteq.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-100.6%
EV/Sales	27.56x
FCF / EV yield	-24.41%
FCF yield	-40.2%
Industry forward P/E	13.86x
Industry P/E	173.47x
P/B ratio	0.54x
P/S ratio	16.74x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	75.54%
Operating margin	-1,351.12%
Pretax margin	-1,501.31%
Profit per employee	$-590,582
Revenue per employee	$39,338
ROA	-17.61%
ROA (5Y)	-8.3%
ROCE	-44.72%
ROE	-42.93%
ROE (5Y)	-20.44%
ROIC	-18.97%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	3,060.15%
Gross profit growth (Q)	48.92%
Gross profit growth 3Y	30.63%
Net income growth years	0
Revenue growth	153.17%
Revenue growth (Q)	48.92%
Revenue growth (QoQ)	0%
Revenue growth 3Y	43.44%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$0
Depreciation and amortization	$870,555
EBIT	$-4.3M
EBITDA	$-3.4M
EPS	$-0.47
FCF per share	$-0.19
Financing cash flow	$319,604
Free cash flow	$-2.1M
Gross profit	$237,728
Investing cash flow	$-316,047
Net borrowing	$-175,519
Net cash flow	$-2.1M
Net income	$-4.7M
Operating income	$-4.3M
Revenue	$314,701

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-0.54
Book value per share	$0.85
Debt / equity	0.36
Interest coverage	-2.93
Long-term assets	$13M
Long-term liabilities	$-179,292
Net cash (debt)	$-3.4M
Net cash / market cap	-64.64%
Net debt / equity	0.36
Piotroski F-Score	2
Property, plant and equipment	$9,654
Shareholders' equity	$9.5M
Tangible book value	$-3.4M
Tangible book value per share	$-0.30
Total assets	$13.4M
Total cash	$6,236
Total debt	$3.4M
Total liabilities	$4M
WACC	14.48%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.02
Current assets	$375,027
Current liabilities	$4.1M
Current ratio	0.09
Inventory turnover	3.63
Net working capital	$-164,999
Quick ratio	0.07
Working capital	$-3.6M
Working capital turnover	-0.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-21.92%
Dividend yield	0%
Shareholder yield	-21.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$0.60
1D price change	1.72%
1M price change	-14.62%
1M total return	-14.62%
1W price change	6%
1W total return	6%
1Y price change	-61.47%
1Y return CAGR	-61.5%
1Y total return	-61.47%
20-day SMA	$0.48
200-day SMA	$0.66
3M price change	-29.47%
3M total return	-29.47%
50-day SMA	$0.56
50-day SMA vs 200-day SMA	50under200
52-week high	$2.01
52-week high date	2026-06-11
52-week low	$0.39
52-week low date	2026-05-20
6M price change	-32.92%
6M total return	-32.92%
All-time high	$5.50
All-time high date	2024-12-10
All-time low	$0.39
All-time low date	2026-05-20
Average true range (ATR)	$0.05
Average volume	93.4K
Beta (1Y)	1.43
Beta (2Y)	2.61
Beta (5Y)	-0.39
Change from 52-week high	-76.81%
Change from 52-week low	20.47%
Change from all-time high	-91.52%
Change from all-time low	20.47%
Change from open	1%
Day's gap	0.72%
Dollar volume	$5,476
High price	$0.47
Low price	$0.46
Monthly RSI	31.33
Open price	$0.46
Position in 52-week range	100%
Premarket change	-1.81%
Premarket close	$0.46
Premarket price	$0.45
Premarket volume	205
Previous close	$0.46
Price vs 150-day SMA	-22.87%
Price vs 20-day SMA	-3.58%
Price vs 200-day SMA	-29.86%
Price vs 50-day SMA	-17.4%
Relative volume	0.13
Return from IPO open	-88.23%
Return from IPO price	-88.23%
RSI	43.69
Sharpe ratio	0.24
Sortino ratio	0.75
Volume	11.7K
Weekly RSI	43.09
YTD price change	-41.73%
YTD total return	-41.73%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5.2M
Float percentage	46.06%
Shares change (QoQ)	0%
Shares change (YoY)	21.92%
Shares held by insiders	29.64%
Shares held by institutions	2.55%
Shares outstanding	11.2M
Short % of float	10.11%
Short % of shares	4.66%
Short ratio	0.1 days

Deeper analysis on GELS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this GELS report

Is a complete GELS research report available?

No complete published report is available for Gelteq Limited (GELS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Gelteq Limited (GELS)

Price

Financial snapshot

Fair-value bridge

Latest news · GELS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GELS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on GELS

Frequently asked questions